Helmut Schiffl1, Rainald Fischer. 1. Department of Internal Medicine-Campus Innenstadt, University of Munich, Munich, Germany. helmut.schiffl@kfh-dialyse.de
Abstract
BACKGROUND: Current research priorities in critical care medicine are focusing on long-term outcomes of survivors of critical illness. Severe acute kidney injury (AKI) is a common occurrence in intensive care. However, few studies have followed up these patients beyond 12 months after hospital discharge. METHODS: Of a cohort of 425 patients, 226 survivors with severe AKI necessitating renal replacement therapy (RRT) were followed up for 60 months after hospital discharge. None of these patients had pre-existing kidney disease. Vital status and renal function were documented annually for 5 years. RESULTS: None of the discharged or transferred patients was dependent on RRT; 57% had complete recovery and 43% had partial recovery of renal function. During the first year after hospital discharge, 18% of survivors died, during the second year 4% and during the third to fifth year 2% per year. At 5 years, 25% of the cohort were still alive. Further improvement in renal function (eGFR) was noted in 26 patients within the first year only. Deterioration of renal function occurred in eight patients. At 5 years, renal function was normal in 86% of the remaining survivors, it was impaired in 9% and 5% of the patients alive needed dialysis again. The proportional Cox regression analysis model showed that pre-existing extrarenal comorbidity, surgery and partial recovery of renal function were independent determinants of long-term survival. CONCLUSIONS: This prospective observational study indicates that severe AKI is not only a determinant of excess in-hospital case fatalities of critically ill patients, but it also carries significant implications for long-term mortality.
BACKGROUND: Current research priorities in critical care medicine are focusing on long-term outcomes of survivors of critical illness. Severe acute kidney injury (AKI) is a common occurrence in intensive care. However, few studies have followed up these patients beyond 12 months after hospital discharge. METHODS: Of a cohort of 425 patients, 226 survivors with severe AKI necessitating renal replacement therapy (RRT) were followed up for 60 months after hospital discharge. None of these patients had pre-existing kidney disease. Vital status and renal function were documented annually for 5 years. RESULTS: None of the discharged or transferred patients was dependent on RRT; 57% had complete recovery and 43% had partial recovery of renal function. During the first year after hospital discharge, 18% of survivors died, during the second year 4% and during the third to fifth year 2% per year. At 5 years, 25% of the cohort were still alive. Further improvement in renal function (eGFR) was noted in 26 patients within the first year only. Deterioration of renal function occurred in eight patients. At 5 years, renal function was normal in 86% of the remaining survivors, it was impaired in 9% and 5% of the patients alive needed dialysis again. The proportional Cox regression analysis model showed that pre-existing extrarenal comorbidity, surgery and partial recovery of renal function were independent determinants of long-term survival. CONCLUSIONS: This prospective observational study indicates that severe AKI is not only a determinant of excess in-hospital case fatalities of critically ill patients, but it also carries significant implications for long-term mortality.
Authors: T M Muniraju; M H Lillicrap; J L Horrocks; J M Fisher; R M W Clark; N S Kanagasundaram Journal: Clin Med (Lond) Date: 2012-06 Impact factor: 2.659
Authors: Harin Rhee; Gum Sook Jang; Yeo Jin An; Miyeun Han; Inseong Park; Il Young Kim; Eun Young Seong; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Sang Heon Song Journal: Clin Exp Nephrol Date: 2018-06-11 Impact factor: 2.801
Authors: Steven M Handler; Pui Wen Cheung; Colleen M Culley; Subashan Perera; Sandra L Kane-Gill; John A Kellum; Zachary A Marcum Journal: J Am Med Dir Assoc Date: 2014-05-10 Impact factor: 4.669
Authors: Katherine E Lynch; Fatimah Ghassemi; Jennifer E Flythe; Mengling Feng; Marzyeh Ghassemi; Leo Anthony Celi; Steven M Brunelli Journal: Nephrology (Carlton) Date: 2016-10 Impact factor: 2.506
Authors: Susanne Stads; Gijs Fortrie; Jasper van Bommel; Robert Zietse; Michiel G H Betjes Journal: Clin J Am Soc Nephrol Date: 2013-04-18 Impact factor: 8.237
Authors: Chi-yuan Hsu; Glenn M Chertow; Charles E McCulloch; Dongjie Fan; Juan D Ordoñez; Alan S Go Journal: Clin J Am Soc Nephrol Date: 2009-04-30 Impact factor: 8.237